Prescription Analytics

2023 Drug Wastage Rule to Impact Pharma Manufacturers

2023 Drug Wastage Rule to Impact Pharma Manufacturers

2023 DRUG WASTAGE RULE TO IMPACTPHARMA MANUFACTURERSPharmaceutical manufacturers continue to experience regulatory and program changes that result in new rebates and/or penalties which have the potential to negatively impact profitability. Last year, the Inflation...

CMS Enforcement for ASP in Medicare Part B

CMS Enforcement for ASP in Medicare Part B

CMS Enforcement of Average Sales Price (ASP) Submissions for all Medicare Part B Eligible Pharmaceuticals and BiopharmaceuticalsRecently, CMS has been sending letters to pharma and biopharma manufacturers (with and without MDRP agreements) indicating that they...

Top 3 Reasons Your AMP Changed

Top 3 Reasons Your AMP Changed

Top 3 Reasons Your AMP ChangedLarge variances in Average Manufacturer Price (AMP) values are a common source of inquiry for pharmaceutical manufacturers. Questions often arise when internal stakeholders are trying to understand an undesired rebate liability or a...